Season 1 Episode 522
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. President Trump has once again delayed the imposition of 100% tariffs on pharmaceuticals, with preparations now set to begin on October 1. Halozyme's acquisition of Elektrofi for $900 million has brought two major pharmaceutical partners together, while Takeda is exiting the cell therapy sector and laying off 137 employees. Roche's $3.5 billion takeover of 89bio was driven by the success of Akero's drug, with regulatory documents shedding light on how 89bio's board pushed for the deal. Lotte Biologics is making waves as a multinational CDMO partner with a focus on quality and patient promise. In other news, GSK has announced layoffs, Pfizer has struck a drug pricing deal with Trump, and big pharma companies are exploring M&A funding opportunities. Stay tuned for more updates in the biopharma industry.
Published on 1 week, 2 days ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate